aluates Reports

$ 0.0

Automative

Global Targeted Drugs for Allergic Diseases Market Research Report 2026

Published Date: 2026-04-28

Report Code: QYRE-Auto-35D18981

Global Targeted Drugs for Allergic Diseases Market Research Report 2025

BUY CHAPTERS

Global Targeted Drugs for Allergic Diseases Market Research Report 2026

Code: QYRE-Auto-35D18981

Report

2026-04-28

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

AbbVie

Novartis

Incyte

Roche

Astrazeneca plc

GSK

Eli Lilly and Company

Amgen Inc

Pfizer Inc

LEO Pharma

TEVA

Otsuka Pharmaceutical

Mabpharm

Targeted Drugs for Allergic Diseases Market Size

The global Targeted Drugs for Allergic Diseases market was valued at US$ 47830 million in 2025 and is anticipated to reach US$ 133870 million by 2032, at a CAGR of 16.1% from 2026 to 2032.

Targeted Drugs for Allergic Diseases Market

Anaphylaxis is an inappropriate reaction of the immune system to normal harmless substances. It generally has a rapid onset, strong reaction, and rapid subsidence. It has obvious genetic tendencies and individual differences. Currently, the prevalence of allergic diseases is increasing rapidly worldwide, affecting approximately 25% of the global population.

Abnormalities in type 2 immune pathways are important factors in inducing allergic diseases. Type 2 immune pathway refers to an inflammatory pathway in which Th2 cells (T helper 2) play a key role, and various cytokines such as IL-4, IL-5, IL-13, and TSLP are involved. Depending on where the inflammatory reaction occurs, abnormal type 2 immune pathways can induce different allergic diseases, such as skin (atopic dermatitis, chronic spontaneous urticaria, etc.), respiratory tract (chronic sinusitis, asthma, chronic obstruction, etc.) lung disease, etc.), digestive tract (eosinophilic esophagitis), cardiovascular (eosinophilic granulomatous vasculitis), etc.

Biological targeted drugs mainly reduce the inflammatory response and activity of immune cells by binding to targets such as specific regulatory factors in the type 2 immune pathway; Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.

Global key players of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, etc. The top five players hold a share over 76%. North America is the largest market, and has a share about 68%, followed by Europe with share 18%. In terms of product type, IL-4R is the largest segment, occupied for a share of 37%. In terms of application, Asthma has a share about 35 percent. The market for targeted drugs for allergic diseases is experiencing steady development driven by advances in immunology, biotechnology, and precision medicine. With growing understanding of molecular pathways involved in allergic responses, pharmaceutical companies are shifting toward biologics and monoclonal antibodies that offer improved efficacy and reduced side effects compared to conventional treatments. The market is also benefiting from increased diagnosis rates, heightened patient awareness, and a focus on chronic allergy management. However, high development costs, regulatory complexity, and access limitations in certain regions may temper rapid expansion. Overall, the sector presents strong potential for innovation and long-term growth as research continues to refine therapeutic targets and enhance treatment personalization.

This report delivers a comprehensive overview of the global Targeted Drugs for Allergic Diseases market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted Drugs for Allergic Diseases. The Targeted Drugs for Allergic Diseases market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Targeted Drugs for Allergic Diseases market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Targeted Drugs for Allergic Diseases manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Targeted Drugs for Allergic Diseases Market Report

Report Metric	Details
Report Name	Targeted Drugs for Allergic Diseases Market
Accounted market size in 2025	US$ 47830 million
Forecasted market size in 2032	US$ 133870 million
CAGR	16.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	IL-4R TSLP IL-5 JAK IgE IL-13 Others
Segment by Application	Atopic Dermatitis Asthma Chronic Sinusitis with Nasal Polyps Chronic Obstructive Pulmonary Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, Leo Pharma, Teva, Otsuka Pharmaceutical, Mabpharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Targeted Drugs for Allergic Diseases companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Targeted Drugs for Allergic Diseases Market growing?

Ans: The Targeted Drugs for Allergic Diseases Market witnessing a CAGR of 16.1% during the forecast period 2026-2032.

What is the Targeted Drugs for Allergic Diseases Market size in 2032?

Ans: The Targeted Drugs for Allergic Diseases Market size in 2032 will be US$ 133870 million.

What is the market share of major companies in Targeted Drugs for Allergic Diseases Market?

Ans: The top five players hold a share over 76%.

What is the Targeted Drugs for Allergic Diseases Market share by type?

Ans: In terms of product type, IL-4R is the largest segment, occupied for a share of 37%.

Who are the main players in the Targeted Drugs for Allergic Diseases Market report?

Ans: The main players in the Targeted Drugs for Allergic Diseases Market are Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, Leo Pharma, Teva, Otsuka Pharmaceutical, Mabpharm

What are the Application segmentation covered in the Targeted Drugs for Allergic Diseases Market report?

Ans: The Applications covered in the Targeted Drugs for Allergic Diseases Market report are Atopic Dermatitis, Asthma, Chronic Sinusitis with Nasal Polyps, Chronic Obstructive Pulmonary Disease, Others

What are the Type segmentation covered in the Targeted Drugs for Allergic Diseases Market report?

Ans: The Types covered in the Targeted Drugs for Allergic Diseases Market report are IL-4R, TSLP, IL-5, JAK, IgE, IL-13, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 IL-4R

1.2.3 TSLP

1.2.4 IL-5

1.2.5 JAK

1.2.6 IgE

1.2.7 IL-13

1.2.8 Others

1.3 Market by Application

1.3.1 Global Targeted Drugs for Allergic Diseases Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Atopic Dermatitis

1.3.3 Asthma

1.3.4 Chronic Sinusitis with Nasal Polyps

1.3.5 Chronic Obstructive Pulmonary Disease

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted Drugs for Allergic Diseases Market Perspective (2021–2032)

2.2 Global Targeted Drugs for Allergic Diseases Growth Trends by Region

2.2.1 Global Targeted Drugs for Allergic Diseases Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Targeted Drugs for Allergic Diseases Historic Market Size by Region (2021–2026)

2.2.3 Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2027–2032)

2.3 Targeted Drugs for Allergic Diseases Market Dynamics

2.3.1 Targeted Drugs for Allergic Diseases Industry Trends

2.3.2 Targeted Drugs for Allergic Diseases Market Drivers

2.3.3 Targeted Drugs for Allergic Diseases Market Challenges

2.3.4 Targeted Drugs for Allergic Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted Drugs for Allergic Diseases Players by Revenue

3.1.1 Global Top Targeted Drugs for Allergic Diseases Players by Revenue (2021–2026)

3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2021–2026)

3.2 Global Top Targeted Drugs for Allergic Diseases Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Targeted Drugs for Allergic Diseases Revenue

3.4 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio

3.4.1 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted Drugs for Allergic Diseases Revenue in 2025

3.5 Global Key Players of Targeted Drugs for Allergic Diseases Head Offices and Areas Served

3.6 Global Key Players of Targeted Drugs for Allergic Diseases, Products and Applications

3.7 Global Key Players of Targeted Drugs for Allergic Diseases, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Targeted Drugs for Allergic Diseases Breakdown Data by Type

4.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Type (2021–2026)

4.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2027–2032)

5 Targeted Drugs for Allergic Diseases Breakdown Data by Application

5.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Application (2021–2026)

5.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Targeted Drugs for Allergic Diseases Market Size (2021–2032)

6.2 North America Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Targeted Drugs for Allergic Diseases Market Size by Country (2021–2026)

6.4 North America Targeted Drugs for Allergic Diseases Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted Drugs for Allergic Diseases Market Size (2021–2032)

7.2 Europe Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2021–2026)

7.4 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Targeted Drugs for Allergic Diseases Market Size (2021–2032)

8.2 Asia-Pacific Targeted Drugs for Allergic Diseases Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (2021–2026)

8.4 Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Targeted Drugs for Allergic Diseases Market Size (2021–2032)

9.2 Latin America Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2021–2026)

9.4 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size (2021–2032)

10.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2021–2026)

10.4 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Targeted Drugs for Allergic Diseases Introduction

11.1.4 Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.1.5 Sanofi Recent Development

11.2 AbbVie

11.2.1 AbbVie Company Details

11.2.2 AbbVie Business Overview

11.2.3 AbbVie Targeted Drugs for Allergic Diseases Introduction

11.2.4 AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.2.5 AbbVie Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Targeted Drugs for Allergic Diseases Introduction

11.3.4 Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.3.5 Novartis Recent Development

11.4 Incyte

11.4.1 Incyte Company Details

11.4.2 Incyte Business Overview

11.4.3 Incyte Targeted Drugs for Allergic Diseases Introduction

11.4.4 Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.4.5 Incyte Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Targeted Drugs for Allergic Diseases Introduction

11.5.4 Roche Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.5.5 Roche Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Introduction

11.6.4 AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.6.5 AstraZeneca Recent Development

11.7 GSK

11.7.1 GSK Company Details

11.7.2 GSK Business Overview

11.7.3 GSK Targeted Drugs for Allergic Diseases Introduction

11.7.4 GSK Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.7.5 GSK Recent Development

11.8 Eli Lilly and Company

11.8.1 Eli Lilly and Company Company Details

11.8.2 Eli Lilly and Company Business Overview

11.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Introduction

11.8.4 Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.8.5 Eli Lilly and Company Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Targeted Drugs for Allergic Diseases Introduction

11.9.4 Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.9.5 Amgen Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Targeted Drugs for Allergic Diseases Introduction

11.10.4 Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.10.5 Pfizer Recent Development

11.11 Leo Pharma

11.11.1 Leo Pharma Company Details

11.11.2 Leo Pharma Business Overview

11.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Introduction

11.11.4 Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.11.5 Leo Pharma Recent Development

11.12 Teva

11.12.1 Teva Company Details

11.12.2 Teva Business Overview

11.12.3 Teva Targeted Drugs for Allergic Diseases Introduction

11.12.4 Teva Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.12.5 Teva Recent Development

11.13 Otsuka Pharmaceutical

11.13.1 Otsuka Pharmaceutical Company Details

11.13.2 Otsuka Pharmaceutical Business Overview

11.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Introduction

11.13.4 Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.13.5 Otsuka Pharmaceutical Recent Development

11.14 Mabpharm

11.14.1 Mabpharm Company Details

11.14.2 Mabpharm Business Overview

11.14.3 Mabpharm Targeted Drugs for Allergic Diseases Introduction

11.14.4 Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2021–2026)

11.14.5 Mabpharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

AbbVie

Novartis

Incyte

Roche

Astrazeneca plc

GSK

Eli Lilly and Company

Amgen Inc

Pfizer Inc

LEO Pharma

TEVA

Otsuka Pharmaceutical

Mabpharm

List of Tables

Table 1. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of IL-4R

Table 3. Key Players of TSLP

Table 4. Key Players of IL-5

Table 5. Key Players of JAK

Table 6. Key Players of IgE

Table 7. Key Players of IL-13

Table 8. Key Players of Others

Table 9. Global Targeted Drugs for Allergic Diseases Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million), 2021–2026

Table 12. Global Targeted Drugs for Allergic Diseases Market Share by Region (2021–2026)

Table 13. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Targeted Drugs for Allergic Diseases Market Share by Region (2027–2032)

Table 15. Targeted Drugs for Allergic Diseases Market Trends

Table 16. Targeted Drugs for Allergic Diseases Market Drivers

Table 17. Targeted Drugs for Allergic Diseases Market Challenges

Table 18. Targeted Drugs for Allergic Diseases Market Restraints

Table 19. Global Targeted Drugs for Allergic Diseases Revenue by Players (US$ Million), 2021–2026

Table 20. Global Targeted Drugs for Allergic Diseases Market Share by Players (2021–2026)

Table 21. Global Top Targeted Drugs for Allergic Diseases Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted Drugs for Allergic Diseases Revenue, 2025

Table 22. Ranking of Global Top Targeted Drugs for Allergic Diseases Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Targeted Drugs for Allergic Diseases Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Targeted Drugs for Allergic Diseases, Headquarters and Area Served

Table 25. Global Key Players of Targeted Drugs for Allergic Diseases, Products and Applications

Table 26. Global Key Players of Targeted Drugs for Allergic Diseases, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Targeted Drugs for Allergic Diseases Market Size by Type (US$ Million), 2021–2026

Table 29. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2021–2026)

Table 30. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2027–2032)

Table 32. Global Targeted Drugs for Allergic Diseases Market Size by Application (US$ Million), 2021–2026

Table 33. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2021–2026)

Table 34. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2027–2032)

Table 36. North America Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2021–2026

Table 38. North America Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (US$ Million), 2027–2032

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Targeted Drugs for Allergic Diseases Product

Table 54. Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 55. Sanofi Recent Development

Table 56. AbbVie Company Details

Table 57. AbbVie Business Overview

Table 58. AbbVie Targeted Drugs for Allergic Diseases Product

Table 59. AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 60. AbbVie Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Targeted Drugs for Allergic Diseases Product

Table 64. Novartis Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 65. Novartis Recent Development

Table 66. Incyte Company Details

Table 67. Incyte Business Overview

Table 68. Incyte Targeted Drugs for Allergic Diseases Product

Table 69. Incyte Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 70. Incyte Recent Development

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche Targeted Drugs for Allergic Diseases Product

Table 74. Roche Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 75. Roche Recent Development

Table 76. AstraZeneca Company Details

Table 77. AstraZeneca Business Overview

Table 78. AstraZeneca Targeted Drugs for Allergic Diseases Product

Table 79. AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 80. AstraZeneca Recent Development

Table 81. GSK Company Details

Table 82. GSK Business Overview

Table 83. GSK Targeted Drugs for Allergic Diseases Product

Table 84. GSK Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 85. GSK Recent Development

Table 86. Eli Lilly and Company Company Details

Table 87. Eli Lilly and Company Business Overview

Table 88. Eli Lilly and Company Targeted Drugs for Allergic Diseases Product

Table 89. Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 90. Eli Lilly and Company Recent Development

Table 91. Amgen Company Details

Table 92. Amgen Business Overview

Table 93. Amgen Targeted Drugs for Allergic Diseases Product

Table 94. Amgen Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 95. Amgen Recent Development

Table 96. Pfizer Company Details

Table 97. Pfizer Business Overview

Table 98. Pfizer Targeted Drugs for Allergic Diseases Product

Table 99. Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 100. Pfizer Recent Development

Table 101. Leo Pharma Company Details

Table 102. Leo Pharma Business Overview

Table 103. Leo Pharma Targeted Drugs for Allergic Diseases Product

Table 104. Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 105. Leo Pharma Recent Development

Table 106. Teva Company Details

Table 107. Teva Business Overview

Table 108. Teva Targeted Drugs for Allergic Diseases Product

Table 109. Teva Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 110. Teva Recent Development

Table 111. Otsuka Pharmaceutical Company Details

Table 112. Otsuka Pharmaceutical Business Overview

Table 113. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product

Table 114. Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 115. Otsuka Pharmaceutical Recent Development

Table 116. Mabpharm Company Details

Table 117. Mabpharm Business Overview

Table 118. Mabpharm Targeted Drugs for Allergic Diseases Product

Table 119. Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (US$ Million), 2021–2026

Table 120. Mabpharm Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Targeted Drugs for Allergic Diseases Picture

Figure 2. Global Targeted Drugs for Allergic Diseases Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Targeted Drugs for Allergic Diseases Market Share by Type: 2025 vs 2032

Figure 4. IL-4R Features

Figure 5. TSLP Features

Figure 6. IL-5 Features

Figure 7. JAK Features

Figure 8. IgE Features

Figure 9. IL-13 Features

Figure 10. Others Features

Figure 11. Global Targeted Drugs for Allergic Diseases Market Size by Application (US$ Million), 2021–2032

Figure 12. Global Targeted Drugs for Allergic Diseases Market Share by Application: 2025 vs 2032

Figure 13. Atopic Dermatitis Case Studies

Figure 14. Asthma Case Studies

Figure 15. Chronic Sinusitis with Nasal Polyps Case Studies

Figure 16. Chronic Obstructive Pulmonary Disease Case Studies

Figure 17. Others Case Studies

Figure 18. Targeted Drugs for Allergic Diseases Report Years Considered

Figure 19. Global Targeted Drugs for Allergic Diseases Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 20. Global Targeted Drugs for Allergic Diseases Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Targeted Drugs for Allergic Diseases Market Share by Region: 2025 vs 2032

Figure 22. Global Targeted Drugs for Allergic Diseases Market Share by Players in 2025

Figure 23. Global Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. The Top 10 and 5 Players Market Share by Targeted Drugs for Allergic Diseases Revenue in 2025

Figure 25. North America Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. North America Targeted Drugs for Allergic Diseases Market Share by Country (2021–2032)

Figure 27. United States Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Canada Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Europe Targeted Drugs for Allergic Diseases Market Share by Country (2021–2032)

Figure 31. Germany Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. France Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. U.K. Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Italy Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Russia Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Ireland Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Asia-Pacific Targeted Drugs for Allergic Diseases Market Share by Region (2021–2032)

Figure 39. China Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Japan Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. South Korea Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Southeast Asia Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. India Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Australia & New Zealand Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Latin America Targeted Drugs for Allergic Diseases Market Share by Country (2021–2032)

Figure 47. Mexico Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Brazil Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Country (2021–2032)

Figure 51. Israel Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Saudi Arabia Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. UAE Targeted Drugs for Allergic Diseases Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Sanofi Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 55. AbbVie Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 56. Novartis Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 57. Incyte Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 58. Roche Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 59. AstraZeneca Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 60. GSK Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 61. Eli Lilly and Company Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 62. Amgen Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 63. Pfizer Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 64. Leo Pharma Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 65. Teva Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 66. Otsuka Pharmaceutical Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 67. Mabpharm Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2021–2026)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Allergy Treatment Market Research Report 2025

Global Food Allergy Treatment Market Research Report 2024

Global Anaphylaxis Treatment Market Research Report 2024

Global Food Allergy Diagnostics and Therapeutics Market Research Report 2024

Global Asthma Therapeutics Market Research Report 2025

Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024

Global Allergic Asthma Therapeutics Market Research Report 2025

Global Immune System Allergy Treatment Market Research Report 2025

Global Drugs to Treat Allergic Diseases Market Research Report 2024

Global Allergy Rhinitis Drug Market Research Report 2025

Global Anti allergic Drugs Market Research Report 2025

Global Peanut Allergy Therapeutics Market Research Report 2024

Generic Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Allergy Rhinitis Drugs Market Research Report 2024

Hay Fever and Allergic Rhinitis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Allergy Diagnostics And Treatment Market

Global Cat Allergy Medicine Market Research Report 2024

Allergic Rhinitis Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions